bf/NASDAQ:MRNA_icon.jpeg

NASDAQ:MRNA

Moderna Inc.

  • Stock

USD

Last Close

132.68

17/05 20:00

Market Cap

38.82B

Beta: 1.70

Volume Today

2.70M

Avg: 3.57M

PE Ratio

−10.50

PFCF: −13.71

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-216.21M
-
-255.92M
18.36%
-384.73M
50.34%
-514.02M
33.60%
-747.06M
45.34%
12.20B
1,733.33%
8.36B
31.47%
-4.71B
156.37%
depreciation and amortization
15.11M
-
20.54M
35.88%
24.86M
21.06%
31.02M
24.77%
31.25M
0.74%
232M
642.38%
348M
50%
621M
78.45%
deferred income tax
10.42M
-
-318M
3,150.95%
-559M
75.79%
828M
248.12%
stock based compensation
39.36M
-
40.05M
1.77%
72.56M
81.16%
81.12M
11.79%
93.02M
14.67%
142M
52.65%
226M
59.15%
305M
34.96%
change in working capital
225.99M
-
-137.25M
160.73%
-42.58M
68.97%
-53.66M
26.02%
2.58B
4,902.20%
990M
61.58%
-3.46B
448.99%
-139M
95.98%
accounts receivables
52.34M
-
106K
99.80%
832K
684.91%
7.22M
767.31%
-1.39B
19,296.11%
-1.78B
28.79%
1.79B
200.34%
493M
72.46%
inventory
-582K
-
34.80M
6,079.90%
4.41M
87.33%
7.20M
63.41%
-46.53M
745.94%
-1.39B
2,896.11%
492M
135.29%
747M
51.83%
accounts payables
5.99M
-
-12.77M
313.02%
15.02M
217.63%
-23.96M
259.58%
11.88M
149.55%
204M
1,617.89%
240M
17.65%
13M
94.58%
other working capital
168.25M
-
-159.39M
194.74%
-62.84M
60.57%
-44.12M
29.79%
4.00B
9,159.36%
3.96B
0.82%
-5.98B
250.78%
-1.39B
76.71%
other non cash items
2.48M
-
1.09M
56.17%
-975K
189.78%
-3.43M
251.38%
62.29M
1,918.04%
372M
497.24%
59M
84.14%
-19M
132.20%
net cash provided by operating activities
66.73M
-
-331.48M
596.72%
-330.87M
0.19%
-458.97M
38.72%
2.03B
541.64%
13.62B
571.94%
4.98B
63.43%
-3.12B
162.60%
investments in property plant and equipment
-33.14M
-
-58.40M
76.20%
-105.77M
81.10%
-31.55M
70.17%
-67.45M
113.75%
-284M
321.07%
-400M
40.85%
-707M
76.75%
acquisitions net
-17M
-
1.60B
9,535.29%
-85M
-
purchases of investments
-1.42B
-
-727.20M
48.62%
-1.23B
68.83%
-1.15B
6.72%
-2.96B
158.14%
-12.65B
327.97%
-11.44B
9.62%
-3.76B
67.12%
sales maturities of investments
808.90M
-
1.20B
48.72%
960.38M
20.17%
1.16B
20.98%
1.35B
16.35%
4.44B
228.67%
6.70B
50.78%
8.78B
31.08%
other investing activites
-8.90M
-
-1.27M
85.74%
622K
149.01%
17M
2,633.12%
-1.60B
9,535.29%
-30M
98.13%
-40M
33.33%
-23M
42.50%
net cash used for investing activites
-648.61M
-
416.10M
164.15%
-372.47M
189.52%
-14.95M
95.99%
-1.67B
11,087.21%
-8.52B
409.77%
-5.18B
39.27%
4.21B
181.26%
debt repayment
-2.17M
-
-6.21M
-
-140M
2,152.61%
-184M
31.43%
-270M
46.74%
common stock issued
563.03M
-
47.26M
91.61%
1.85B
3,820.36%
124M
93.31%
65M
47.58%
46M
29.23%
common stock repurchased
-8.18M
-
2.89M
135.33%
7.04M
143.51%
-857M
12,273.30%
-3.33B
288.45%
-1.15B
65.36%
dividends paid
-7.04M
-
-124M
1,661.36%
-184M
48.39%
-270M
46.74%
other financing activites
472.91M
-
168K
99.96%
674.17M
401,193.45%
971K
99.86%
186.68M
19,125.85%
124M
33.58%
184M
48.39%
270M
46.74%
net cash used provided by financing activities
472.91M
-
168K
99.96%
1.23B
730,163.10%
51.12M
95.83%
2.03B
3,877.22%
-873M
142.94%
-3.45B
294.96%
-1.38B
60.06%
effect of forex changes on cash
net change in cash
-108.96M
-
84.78M
177.81%
523.50M
517.49%
-422.79M
180.76%
2.39B
664.87%
4.22B
76.87%
-3.64B
186.25%
-289M
92.07%
cash at beginning of period
159.04M
-
50.08M
68.51%
134.86M
169.29%
670.49M
397.18%
247.70M
63.06%
2.64B
964.19%
6.86B
160.24%
3.22B
53.10%
cash at end of period
50.08M
-
134.86M
169.29%
658.36M
388.19%
247.70M
62.38%
2.64B
964.17%
6.86B
160.25%
3.22B
53.10%
2.93B
8.98%
operating cash flow
66.73M
-
-331.48M
596.72%
-330.87M
0.19%
-458.97M
38.72%
2.03B
541.64%
13.62B
571.94%
4.98B
63.43%
-3.12B
162.60%
capital expenditure
-33.14M
-
-58.40M
76.20%
-105.77M
81.10%
-31.55M
70.17%
-67.45M
113.75%
-284M
321.07%
-400M
40.85%
-707M
76.75%
free cash flow
33.59M
-
-389.88M
1,260.72%
-436.63M
11.99%
-490.52M
12.34%
1.96B
499.48%
13.34B
580.57%
4.58B
65.65%
-3.83B
183.50%

All numbers in USD (except ratios and percentages)